● The company's share price in relation to its net book value makes it look relatively cheap.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.